Lyra Therapeutics (LYRA) Prepaid Assets (2019 - 2025)
Quarterly Prepaid Assets fell 84.52% to $379000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $379000.0 through Dec 2025, down 84.52% year-over-year, with the annual reading at $379000.0 for FY2025, 84.52% down from the prior year.
Lyra Therapeutics' Prepaid Assets history spans 7 years, with the latest figure at $379000.0 for Q4 2025.
- Prepaid Assets came in at $379000.0 for Q4 2025, down from $964000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.9 million in Q4 2022 to a low of $379000.0 in Q4 2025.
- The 5-year median for Prepaid Assets is $2.1 million (2023), against an average of $1.9 million.
- Year-over-year, Prepaid Assets skyrocketed 325.26% in 2021 and then plummeted 84.52% in 2025.
- Lyra Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then skyrocketed by 35.19% to $2.9 million in 2022, then fell by 29.54% to $2.1 million in 2023, then increased by 18.38% to $2.4 million in 2024, then tumbled by 84.52% to $379000.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Prepaid Assets are $379000.0 (Q4 2025), $964000.0 (Q3 2025), and $1.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 379,000.00 |
| Sep 30, 2025 | 964,000.00 |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 2.09 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 2.17 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Jun 30, 2021 | 1.03 Mn |
| Mar 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 1.32 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 2.71 Mn |
| Mar 31, 2020 | 293,000.00 |
| Dec 31, 2019 | 311,000.00 |